The cancer community is deeply concerned about the unintended consequences of the current wording of the European Union (EU) draft Regulation on Data Protection, which may challenge the survival of retrospective clinical research, biobanking, and [more]
With our new-found understanding of cancer biology comes the opportunity to explain a disease that for centuries has confounded doctors and engendered stigma and superstition. Siddhartha Mukherjee took that opportunity and turned it into a [more]
Once every seven years an opportunity arises to influence the shape of the European science research effort. This editorial takes a look at what is at stake in the current discussions around the European Research [more]
A single infrastructure for Europe’s rapidly evolving biobanks is urgently needed. But finding agreement on the ethics, language and operating standards is proving quite a challenge. Download full article
Europe has money, human resources and a basic-science base that produces world-leading cancer research. Why, then, aren’t these assets being translated into clinical advances? Download full article
Cancer research is being held back by a shortage of high-quality, well-documented biological specimens. However, convincing hospitals to pool their specimens in a regional, national or international biobank is not always easy, adding to the [more]
Silvio Garattini gave up a glittering academic career to found his own set-up where research could be carried out free from commercial or political agendas. Today, the Mario Negri Institute and its founder play a [more]
In its centennial year the AACR maps the landmarks of progress in our understanding of cancer, and calls for renewed commitment to the search for prevention and cure. Download full article
Bringing the new wave of targeted cancer drugs to the market poses new challenges for researchers and clinicians. It is not enough to design a smart drug to hit a molecular target. Researchers need to [more]
Fatima Cardoso’s determination to put her considerable abilities to best use landed her the scientific directorship of a groundbreaking translational research trial at the tender age of 37. A founder of the Flims Alumni Club, [more]
As a young epidemiologist, Peter Boyle once had to give a talk on trends in smoking-related cancer, having lost his father to the disease that same morning. Now head of the IARC, his great strength [more]
It took José Baselga just a few years to build the oncology department at Barcelona’s Vall d’Hebron hospital from a few shabby consulting rooms to a leading centre for research into targeted therapies. Europe has [more]
Do animal models reliably predict toxic effects in humans, or are they actually blocking development of vital new drugs? Two recent major health scares have reignited the old debate. Download full article